Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Lucas

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Nature Communications|January 9, 2015
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphomaZilin Nie, Ming-Qing Du, Linda M McAllister-Lucas, et al.
BMC Bioinformatics|June 19, 2024
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Research Square|December 11, 2023
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2016
Characterizing Molecular Variants and Clinical Utilization of Next-generation Sequencing in Advanced Breast CancerGrzegorz T Gurda, Tadeu Ambros, Marina N Nikiforova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cellsLinda M McAllister-Lucas, Jürgen Ruland, Katy Siu, et al.
Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.
Breast Cancer Research : BCR|January 7, 2021
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrencesNolan Priedigkeit, Kai Ding, William Horne, et al.
Mbio|July 13, 2021
Pneumococcal Extracellular Vesicles Modulate Host ImmunitySaigopalakrishna S Yerneni, Sarah Werner, Juliana H Azambuja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial CellsDanielle N Alfano, Linda R Klei, Hanna B Klei, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Nature Communications|January 9, 2015
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphomaZilin Nie, Ming-Qing Du, Linda M McAllister-Lucas, et al.
BMC Bioinformatics|June 19, 2024
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Research Square|December 11, 2023
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2016
Characterizing Molecular Variants and Clinical Utilization of Next-generation Sequencing in Advanced Breast CancerGrzegorz T Gurda, Tadeu Ambros, Marina N Nikiforova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2006
CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cellsLinda M McAllister-Lucas, Jürgen Ruland, Katy Siu, et al.
Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.
Breast Cancer Research : BCR|January 7, 2021
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrencesNolan Priedigkeit, Kai Ding, William Horne, et al.
Mbio|July 13, 2021
Pneumococcal Extracellular Vesicles Modulate Host ImmunitySaigopalakrishna S Yerneni, Sarah Werner, Juliana H Azambuja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 28, 2020
MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial CellsDanielle N Alfano, Linda R Klei, Hanna B Klei, et al.
Pageof 12